Zhangjiang companies showcase at China import expo
AstraZeneca Investment (China) Co
An exhibition booth of AstraZeneca Investment (China) Co at the China International Import Expo. [Photo/WeChat account: zhangjiangfabu]
AstraZeneca, a world-leading biopharmaceutical company, has been developing businesses in China for 25 years. At the expo, the company targeted therapy areas that Chinese patients need most: respiratory, cardiovascular, metabolic, oncology, gastrointestinal and renal disease, and displayed the 30 innovative drugs that it has brought to China over the past 25 years.
AstraZeneca also showcased its end-to-end disease management solutions that integrate diagnosis and treatment. The solutions are inspired by and based on the latest technologies, such as the internet of things, artificial intelligence and big data.